Immunocore Holdings (IMCR) Other Working Capital Changes (2023 - 2026)

Immunocore Holdings (IMCR) has reported Other Working Capital Changes for 4 consecutive years, with -$864000.0 the latest figure, recorded in Q1 2026.

• Quarterly Other Working Capital Changes fell 214.29% year-over-year to -$864000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.7 million (down 823.63% YoY) and the FY2025 annual result came in at -$2.1 million, down 27.0% from the prior year.
• Other Working Capital Changes advanced to -$864000.0 in Q1 2026 per IMCR's latest filing, from -$2.6 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for IMCR reached as high as $27.2 million in Q4 2023 and fell as low as -$18.1 million in Q1 2023.
• A 4-year average of $3.6 million and a median of $1.9 million in 2024 frame the typical range for Other Working Capital Changes.
• The largest YoY upside for Other Working Capital Changes was 1561.11% in 2025 against a maximum downside of 494.77% in 2025.
• Year by year, Other Working Capital Changes stood at -$8.7 million in 2023, then soared by 94.92% to -$440000.0 in 2024, then sank by 494.77% to -$2.6 million in 2025, then jumped by 66.99% to -$864000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$864000.0, -$2.6 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.